Enzo Biochem (GB:0IHV)
LSE:0IHV
UK Market

Enzo Biochem Stock Analysis & Ratings

GB:0IHV Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$3.33
VolumeN/A
Average Volume (3M)122.00
Market Cap$162.20M
P/E Ratio616.7
Beta0.95
Next EarningsJun 08, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score4
EPS (TTM)0.00


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:0IHV FAQ

What was Enzo Biochem’s price range in the past 12 months?
Enzo Biochem lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Enzo Biochem’s market cap?
    Enzo Biochem’s market cap is $162.20M.
      What is Enzo Biochem’s price target?
      Currently, no data Available
      What do analysts say about Enzo Biochem?
      Not enough analysts have published a price target to provide an average price target.
      When is Enzo Biochem’s upcoming earnings report date?
      Enzo Biochem’s upcoming earnings report date is Jun 08, 2022 which is in 18 days.
        How were Enzo Biochem’s earnings last quarter?
        Enzo Biochem released its earnings results on Mar 14, 2022. The company reported -$0.055 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.055.
          Is Enzo Biochem overvalued?
          According to Wall Street analysts Enzo Biochem’s price is currently Overvalued.
            Does Enzo Biochem pay dividends?
            Enzo Biochem does not currently pay dividends.
            What is Enzo Biochem’s EPS estimate?
            Enzo Biochem’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Enzo Biochem have?
            Enzo Biochem has 48,710,000 shares outstanding.
              What happened to Enzo Biochem’s price movement after its last earnings report?
              Enzo Biochem reported an EPS of -$0.055 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Enzo Biochem?
                Among the largest hedge funds holding Enzo Biochem’s share is Evermore Global Advisors, Llc. It holds Enzo Biochem’s shares valued at N/A.

                  ---

                  Enzo Biochem Stock Analysis

                  Smart Score
                  4
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  Price Target
                  No data currently available
                  The Enzo Biochem stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Enzo Biochem

                  Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Laboratory
                  Quest Diagnostics
                  NeoGenomics
                  Psychemedics
                  Qiagen

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis